Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling MEXILETINE HCL capsules because they may have been mislabeled as CALCIUM ACETATE. The error could lead to patients receiving the wrong medication.
KVK-Tech, Inc. is recalling 249,096 bottles of Hydroxyzine Hydrochloride tablets because the active pharmaceutical ingredient was sourced from an unapproved supplier.
Aidapak Services, LLC is recalling Quinidine Sulfate 200 mg tablets that may have been mislabeled as Quinapril 40 mg. The error occurred during repacking in four western states.
Aidapak Services is recalling 0.5 mg tacrolimus capsules because they may have been mislabeled as cinacalcet or isosorbide mononitrate.
Aidapak Services is recalling 500 mg Ascorbic Acid tablets because they may have been mislabeled as Venlafaxine HCL 100 mg.
Aidapak Services, LLC is recalling 2.5 mg Bromocriptine Mesylate tablets because they may have been mislabeled as Benazepril HCl or Thioridazine HCl.
Aidapak Services, LLC is recalling Valsartan 80 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.
Aidapak Services, LLC is recalling 10 mg Piroxicam capsules because they may have been mislabeled as Hyoscyamine Sulfate. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Estradiol 0.5 mg tablets because they may have been mislabeled as Nicotine Polacrilex gum.
Aidapak Services is recalling Digoxin 125 mcg tablets because they may have been mislabeled as Cholecalciferol/Calcium/Phosphorus tablets.
Aidapak Services, LLC is recalling Doxycycline Hyclate 100 mg capsules because they may have been mislabeled as Raloxifene HCL 60 mg tablets.
Aidapak Services, LLC is recalling multivitamin tablets that may have been mislabeled as sitagliptin or loratadine. The FDA classifies this as a Class II recall.
Aidapak Services is recalling repacked progesterone capsules that may be mislabeled as levothyroxine sodium tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Lorazepam tablets that may have been mislabeled as Tramadol HCl. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Bismuth Subsalicylate chewable tablets that may have been mislabeled as Irbesartan. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling Vitamin B Complex tablets that may have been mislabeled as Cinacalcet HCl. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Tizanidine HCl 2 mg tablets that may have been mislabeled as Niacin TR 500 mg.
Aidapak Services, LLC is recalling Phenobarbital tablets that may have been mislabeled as Efavirenz capsules. The error involves a label mixup during repacking.
Aidapak Services is recalling Efavirenz 200 mg capsules because they may have been mislabeled as metformin HCl 500 mg tablets.
Aidapak Services, LLC is recalling guanfacine HCl tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Liothyronine Sodium 25 mcg tablets because they may have been mislabeled as Levothyroxine Sodium or Hyoscyamine Sulfate.
Aidapak Services is recalling Entecavir tablets because they may be mislabeled as other prescription drugs.
Aidapak Services is recalling Mycophenolic Acid tablets that may be mislabeled as Methazolamide. The error could lead to patients taking the wrong medication.
Novartis is recalling Theraflu and related cold medicine powder packets because they may contain foreign substances. The recall affects products distributed in the US, Canada, Mexico, and other countries.